Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoniou

Showing results (291-300 of 395) with videos related to

Pageof 40
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 4, 2015
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility LociAli Amin Al Olama, Sara Benlloch, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Nature Communications|August 2, 2020
European polygenic risk score for prediction of breast cancer shows similar performance in Asian womenWeang-Kee Ho, Min-Min Tan, Nasim Mavaddat, et al.
NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
Human Molecular Genetics|March 25, 2016
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithmsMiguel de la Hoya, Omar Soukarieh, Irene López-Perolio, et al.
JAMA|January 26, 2012
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancerKelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriersAmanda B Spurdle, Louise Marquart, Lesley McGuffog, et al.
American Journal of Human Genetics|November 14, 2007
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studiesAntonis C Antoniou, Olga M Sinilnikova, Jacques Simard, et al.
Pageof 40

Showing results (291-300 of 395) with videos related to

Sort By:
Pageof 40
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 4, 2015
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility LociAli Amin Al Olama, Sara Benlloch, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Nature Communications|August 2, 2020
European polygenic risk score for prediction of breast cancer shows similar performance in Asian womenWeang-Kee Ho, Min-Min Tan, Nasim Mavaddat, et al.
NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
Human Molecular Genetics|March 25, 2016
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithmsMiguel de la Hoya, Omar Soukarieh, Irene López-Perolio, et al.
JAMA|January 26, 2012
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancerKelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriersAmanda B Spurdle, Louise Marquart, Lesley McGuffog, et al.
American Journal of Human Genetics|November 14, 2007
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studiesAntonis C Antoniou, Olga M Sinilnikova, Jacques Simard, et al.
Pageof 40